본문 바로가기 주메뉴 바로가기
  • HOME
  • R&D
  • Current Status of Development
  • Current Status of Clinical Trial

Current Status of Clinical Trial

Efficacy and Safety of Immune cell Therapy Group and Non-treatment Group in
Hepatocelluar Carcinoma Patients
Phase Ⅲ Shortcuts
  • Seoul National University Hospital
    Seoul National University Hospital
    Seoul, Republic of Korea
    Principal Investigator: Jung Hwan Yoon, MD
  • Samsung Medical Center
    Samsung Medical Center
    Seoul, Republic of Korea
  • Seoul Asan Medical Center
    Seoul Asan Medical Center
    Seoul, Republic of Korea
  • Korea University Ansan Hospital
    Korea University Ansan Hospital
    Gyeonggi-do, Republic of Korea
  • Korea University Guro Hospital
    Korea University Guro Hospital
    Seoul, Republic of Korea
Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in
Hepatocellular Carcinoma Patients
Phase Ⅳ Shortcuts
  • Seoul National University Hospital
    Seoul National University Hospital
    Seoul, Republic of Korea
    Principal Investigator: Jung Hwan Yoon, MD
  • Samsung Medical Center
    Samsung Medical Center
    Seoul, Republic of Korea
  • Seoul Asan Medical Center
    Seoul Asan Medical Center
    Seoul, Republic of Korea
  • Korea University Ansan Hospital
    Korea University Ansan Hospital
    Gyeonggi-do, Republic of Korea
  • Korea University Guro Hospital
    Korea University Guro Hospital
    Seoul, Republic of Korea
Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' With Nexavar in
Advanced Hcc Patients
Phase Ⅱ Shortcuts
  • Korea University Anam Hospital
    Korea University Anam Hospital
    Seoul, Republic of Korea
    Principal Investigator: Soon Ho Um, MD, PhD
  • The Catholic University of Korea, Seoul ST. Mary's Hospital
    The Catholic University of Korea, Seoul ST. Mary's Hospital
    Seoul, Republic of Korea
  • Yonsei University Health System
    Yonsei University Health System
    Seoul, Republic of Korea
  • Inha University Hospital
    Inha University Hospital
    Incheon, Republic of Korea
Clinical Trial to Evaluate the Efficacy and Safety of "Immuncell-LC" in the Patients
Undergone TACE for Intermediate Stage Hepatocellular Carcinoma
Phase Ⅱ Shortcuts
  • Seoul National University Hospital
    Seoul National University Hospital
    Seoul, Republic of Korea
    Principal Investigator: Jung Hwan Yoon, MD
  • The Catholic University of Korea, Seoul ST. Mary's Hospital
    The Catholic University of Korea, Seoul ST. Mary's Hospital
    Seoul, Republic of Korea
  • Gangnam Severance Hospital
    Gangnam Severance Hospital
    Seoul, Republic of Korea